Compare HCM & DAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HCM | DAN |
|---|---|---|
| Founded | 2000 | 1904 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.4B |
| IPO Year | N/A | N/A |
| Metric | HCM | DAN |
|---|---|---|
| Price | $13.35 | $23.84 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $13.75 | ★ $26.40 |
| AVG Volume (30 Days) | 21.1K | ★ 2.2M |
| Earning Date | 08-07-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 1.69% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.53 | 0.39 |
| Revenue | $602,197,000.00 | ★ $9,957,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $15.54 | $2.05 |
| P/E Ratio | ★ $4.90 | $51.58 |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $11.51 | $10.11 |
| 52 Week High | $19.50 | $23.92 |
| Indicator | HCM | DAN |
|---|---|---|
| Relative Strength Index (RSI) | 30.04 | 65.75 |
| Support Level | $13.06 | $22.39 |
| Resistance Level | $13.59 | $23.25 |
| Average True Range (ATR) | 0.24 | 0.73 |
| MACD | -0.02 | 0.11 |
| Stochastic Oscillator | 11.13 | 89.40 |
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
Dana Inc is engaged in the designing and manufacturing of efficient propulsion and energy-management solutions that power vehicles and machines in all mobility markets across the globe. The company has four operating segments: Light Vehicles, Power Technologies, Commercial Vehicle, and Off-Highway. The Light Vehicles segment generates the majority portion of revenue by providing products to support light vehicle OEMs. Its products are designed for light trucks, SUVs, CUVs, vans, and passenger cars.